Copyright Reports & Markets. All rights reserved.

Global Controlled Substances Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Controlled Substances Market Overview

    • 1.1 Product Overview and Scope of Controlled Substances
    • 1.2 Classification of Controlled Substances by Types
      • 1.2.1 Global Controlled Substances Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Controlled Substances Revenue Market Share by Types in 2018
      • 1.2.3 Opioids
      • 1.2.4 Stimulants
      • 1.2.5 Depressants
      • 1.2.6 Marijuana
      • 1.2.7 Others
    • 1.3 Global Controlled Substances Market by Application
      • 1.3.1 Global Controlled Substances Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital Pharmacies
      • 1.3.3 Retail Pharmacies
      • 1.3.4 Online Pharmacies
    • 1.4 Global Controlled Substances Market by Regions
      • 1.4.1 Global Controlled Substances Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Controlled Substances Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Controlled Substances Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Controlled Substances Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Controlled Substances Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Controlled Substances Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Controlled Substances (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Johnson & Johnson
      • 2.1.1 Business Overview
      • 2.1.2 Controlled Substances Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Johnson & Johnson Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Pfizer
      • 2.2.1 Business Overview
      • 2.2.2 Controlled Substances Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Pfizer Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Siegfried AG
      • 2.3.1 Business Overview
      • 2.3.2 Controlled Substances Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Siegfried AG Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 GlaxoSmithKline
      • 2.4.1 Business Overview
      • 2.4.2 Controlled Substances Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 GlaxoSmithKline Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teva Pharmaceuticals
      • 2.5.1 Business Overview
      • 2.5.2 Controlled Substances Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teva Pharmaceuticals Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Mylan
      • 2.6.1 Business Overview
      • 2.6.2 Controlled Substances Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Mylan Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Takeda Pharmaceutical
      • 2.7.1 Business Overview
      • 2.7.2 Controlled Substances Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Takeda Pharmaceutical Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Sun Pharmaceutical
      • 2.8.1 Business Overview
      • 2.8.2 Controlled Substances Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Sun Pharmaceutical Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Daiichi Sankyo
      • 2.9.1 Business Overview
      • 2.9.2 Controlled Substances Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Daiichi Sankyo Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Akorn Inc
      • 2.10.1 Business Overview
      • 2.10.2 Controlled Substances Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Akorn Inc Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Tilray
      • 2.11.1 Business Overview
      • 2.11.2 Controlled Substances Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Tilray Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Medical Marijuana, Inc
      • 2.12.1 Business Overview
      • 2.12.2 Controlled Substances Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Medical Marijuana, Inc Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Consort Medical
      • 2.13.1 Business Overview
      • 2.13.2 Controlled Substances Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Consort Medical Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Purdue Pharma
      • 2.14.1 Business Overview
      • 2.14.2 Controlled Substances Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Purdue Pharma Controlled Substances Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Controlled Substances Market Competition, by Players

    • 3.1 Global Controlled Substances Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Controlled Substances Players Market Share
      • 3.2.2 Top 10 Controlled Substances Players Market Share
    • 3.3 Market Competition Trend

    4 Global Controlled Substances Market Size by Regions

    • 4.1 Global Controlled Substances Revenue and Market Share by Regions
    • 4.2 North America Controlled Substances Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Controlled Substances Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Controlled Substances Revenue and Growth Rate (2014-2019)
    • 4.5 South America Controlled Substances Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Controlled Substances Revenue and Growth Rate (2014-2019)

    5 North America Controlled Substances Revenue by Countries

    • 5.1 North America Controlled Substances Revenue by Countries (2014-2019)
    • 5.2 USA Controlled Substances Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Controlled Substances Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Controlled Substances Revenue and Growth Rate (2014-2019)

    6 Europe Controlled Substances Revenue by Countries

    • 6.1 Europe Controlled Substances Revenue by Countries (2014-2019)
    • 6.2 Germany Controlled Substances Revenue and Growth Rate (2014-2019)
    • 6.3 UK Controlled Substances Revenue and Growth Rate (2014-2019)
    • 6.4 France Controlled Substances Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Controlled Substances Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Controlled Substances Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Controlled Substances Revenue by Countries

    • 7.1 Asia-Pacific Controlled Substances Revenue by Countries (2014-2019)
    • 7.2 China Controlled Substances Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Controlled Substances Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Controlled Substances Revenue and Growth Rate (2014-2019)
    • 7.5 India Controlled Substances Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Controlled Substances Revenue and Growth Rate (2014-2019)

    8 South America Controlled Substances Revenue by Countries

    • 8.1 South America Controlled Substances Revenue by Countries (2014-2019)
    • 8.2 Brazil Controlled Substances Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Controlled Substances Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Controlled Substances Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Controlled Substances by Countries

    • 9.1 Middle East and Africa Controlled Substances Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Controlled Substances Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Controlled Substances Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Controlled Substances Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Controlled Substances Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Controlled Substances Revenue and Growth Rate (2014-2019)

    10 Global Controlled Substances Market Segment by Type

    • 10.1 Global Controlled Substances Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Controlled Substances Market Forecast by Type (2019-2024)
    • 10.3 Opioids Revenue Growth Rate (2014-2024)
    • 10.4 Stimulants Revenue Growth Rate (2014-2024)
    • 10.5 Depressants Revenue Growth Rate (2014-2024)
    • 10.6 Marijuana Revenue Growth Rate (2014-2024)
    • 10.7 Others Revenue Growth Rate (2014-2024)

    11 Global Controlled Substances Market Segment by Application

    • 11.1 Global Controlled Substances Revenue Market Share by Application (2014-2019)
    • 11.2 Controlled Substances Market Forecast by Application (2019-2024)
    • 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
    • 11.4 Retail Pharmacies Revenue Growth (2014-2019)
    • 11.5 Online Pharmacies Revenue Growth (2014-2019)

    12 Global Controlled Substances Market Size Forecast (2019-2024)

    • 12.1 Global Controlled Substances Market Size Forecast (2019-2024)
    • 12.2 Global Controlled Substances Market Forecast by Regions (2019-2024)
    • 12.3 North America Controlled Substances Revenue Market Forecast (2019-2024)
    • 12.4 Europe Controlled Substances Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Controlled Substances Revenue Market Forecast (2019-2024)
    • 12.6 South America Controlled Substances Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Controlled Substances Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Scope of the Report:
      North America has traditionally been the most lucrative market for controlled substances, with sales estimated to record a Y-o-Y of 5.0% in 2019 over 2018. This can be attributes in part to legalization of various forms of marijuana in the US, along with the recent approval of recreational marijuana sales in Canada.
      The global Controlled Substances market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Controlled Substances.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Controlled Substances market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Controlled Substances market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Johnson & Johnson
      Pfizer
      Siegfried AG
      GlaxoSmithKline
      Teva Pharmaceuticals
      Mylan
      Takeda Pharmaceutical
      Sun Pharmaceutical
      Daiichi Sankyo
      Akorn Inc
      Tilray
      Medical Marijuana, Inc
      Consort Medical
      Purdue Pharma

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Opioids
      Stimulants
      Depressants
      Marijuana
      Others

      Market Segment by Applications, can be divided into
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Buy now